Back to search results

Memory Support System for Chinese Americans with Mild Cognitive Impairment

This study is looking at whether the Memory Support System (MSS) from the HABIT Program can help older Chinese Americans who have mild cognitive impairment (MCI), which means they have mild thinking and memory problems. The MSS is a program that teaches strategies to support daily functioning. You would either learn the MSS with a trainer and a study partner over 10 sessions, or you would receive a brain health education course tailored for MCI, also over 10 sessions. The researchers want to see how many people join, how many stay in the study, and how many complete the program. The study is currently unclear on its recruitment status and plans to enroll 7 participants.

Study design
This interventional study is designed to compare two behavioral interventions. It plans to enroll 7 participants.
What's involved
You would participate in 10 sessions over 4-9 weeks, either learning the Memory Support System or attending brain health education sessions.
Compensation
Not stated in the trial record.
Follow-up
The study measures recruitment, retention, and completion rates at baseline and at the end of treatment (4-9 weeks).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07142499

Memory Support System for Older Chinese Americans With Mild Cognitive Impairment

Recruiting
NAAges 55+InterventionalTreatment
Icahn School of Medicine at Mount Sinai
~7 participants
Updated 2025-11-06 on ClinicalTrials.gov
What's tested:Memory Support SystemBrain Health Education

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Recruitment rate
Measured over baseline, week 1 of intervention session
+2 more outcomes measured

Conditions

Mild Cognitive Impairment (MCI)

Explore related trials

Mild cognitive disorder

NCT07142499

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Li Lab, Icahn School of Medicine at Mount Sinai

    New York, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Clara Li, PhD · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai

Who to contact

Clara Li, PhD
[email protected]
212-585-4631
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

self-identify as Chinese American;
age 55 and above;
a diagnosis of MCI as confirmed through documented clinical assessment and/or research-based diagnostic criteria;
predominantly Cantonese- or Mandarin-speaking;
able to read and write in Chinese;
visual and auditory acuity adequate for cognitive testing;
willing to complete the assessment measures;
having someone in regular contact to serve as a study partner/informant;
absence or stable use of prescribed memory-enhancing medications within the last 3 months.

Exclusion

any significant neurologic disease that would impact their participation and completion of the trial;
history of psychiatry disorder (DSM 5 criteria) within the last 12 months;
history of reading or writing disability sufficient to interfere with MSS training; or
concurrent participation in another relevant clinical trial.

What this trial measures

  • Recruitment ratebaseline, week 1 of intervention session

    Recruitment rate will be measured by dividing the number of enrollees over the number of total potential participants approached.

  • Retention ratebaseline, treatment end (4-9 weeks)

    Retention rate will be measured by dividing the number of enrollees who remain in the study over the total number of enrollees.

  • Completion ratebaseline, treatment end (4-9 weeks)

    Completion rate will be measured by dividing the number of enrollees who complete all study procedures over the number of total enrollees.